FDA approves CryoLife's heart patch

08/12/2009 | Forbes

The FDA granted approval to CryoLife for its CryoPatch SG, a human cardiac patch designed to repair or reconstruct the heart's right ventricular outflow tract, a surgery often done for pediatric patients with congenital heart defects. The company plans to start shipping the product late in the third quarter.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN